J&J Lifts Steering in First File After Kenvue Derivative

Biotech and PharmaEarnings ReportBy Josh Nathan-KazisUpdated Oct 17, 2023, 6:40 am EDT / Unique Oct 16, 2023, 5:00 pm EDT*{pointer-events:none;}.css-1ftbuf0-MainStack:has(:focus-visible){outline-color:rgba(54,119,168,1);outline-style:cast;outline-width:3px;outline-offset:1px;}]]>*{pointer-events:none;}.css-ligzvc-MainStack:has(:focus-visible){outline-color:rgba(54,119,168,1);outline-style:cast;outline-width:3px;outline-offset:1px;}]]>ShareReprints stocks rose Tuesday because the pharmaceutical corporate raised its full-year steerage after third- quarter profits beat expectancies. Proceed studying this text with a Barron’s subscription.View Choices

Author: OpenAI